ICD-10-PCS 2027 procedure code
3E0M30YIntroduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
Short description: Introduce Hyperthermic Antneo in Periton Cav, Perc
Code last changed in FY2020 (effective October 1, 2019). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About 3E0M30Y
3E0M30Y is the ICD-10-PCS code for a introduction procedure on the peritoneal cavity using a percutaneous approach with antineoplastic (qualifier: hyperthermic). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2020, effective October 1, 2019.
What each character means
- 1. Section
- 3Administration
- 2. Body System
- EPhysiological Systems and Anatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body System / Region
- MPeritoneal Cavity
- 5. Approach
- 3Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
- 6. Substance
- 0Antineoplastic
Includes: Amivantamab Monoclonal Antibody; Lurbinectedin; RYBREVANT (tm) (Amivantamab Monoclonal Antibody); ZEPZELCA(tm) (Lurbinectedin)
- 7. Qualifier
- YHyperthermic
Other versions of this procedure
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2020 (effective 10/1/2019): Added
- No changes since FY2020.
Common questions about 3E0M30Y
Is 3E0M30Y a valid ICD-10-PCS code for 2027?
- Yes. 3E0M30Y is valid for inpatient procedures from October 1, 2026 through September 30, 2027.